Atossa Therapeutics (ATOS) Treasury Shares (2011 - 2026)
Atossa Therapeutics (ATOS) posted quarterly Treasury Shares of $1.5 million for Q1 2026, little changed year-over-year from $1.5 million in Q1 2025, and little changed quarter-over-quarter from $1.5 million in Q4 2025.
Atossa Therapeutics (ATOS) Treasury Shares (2011 - 2026) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Treasury Shares for 4 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares changed 0.0% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (changed 0.0% YoY), while the FY2025 annual figure was $1.5 million, changed 0.0% from the prior year.
- Treasury Shares was little changed at $1.5 million in Q1 2026 per ATOS's latest filing, from $1.5 million in the prior quarter.
- Across five years, Treasury Shares topped out at $1.3 million in Q4 2023 and bottomed at $88003.0 in Q4 2024.
- Historically, Treasury Shares has averaged $1.0 million across 4 years, with a median of $1.3 million in 2023.
- On a YoY basis, Treasury Shares climbed as much as 870.39% in 2024 and fell as far as 0.0% in 2024.
- Atossa Therapeutics' Treasury Shares stood at $1.5 million in 2023, then changed by 0.0% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
- Business Quant data shows ATOS's Treasury Shares at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | 1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 380,683.00 |
| Jun 30, 2026 | 380,683.00 |
| Jun 30, 2026 | 1.48 Mn |
| Jun 30, 2026 | 1.48 Mn |
| Mar 31, 2026 | 1.48 Mn |
| Mar 31, 2026 | 1.48 Mn |
| Mar 31, 2026 | 313,401.00 |
| Mar 31, 2026 | 313,401.00 |
| Dec 31, 2025 | 1.48 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.48 Mn |
| Sep 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.48 Mn |